Page last updated: 2024-09-04

docetaxel anhydrous and onapristone

docetaxel anhydrous has been researched along with onapristone in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(onapristone)
Trials
(onapristone)
Recent Studies (post-2010) (onapristone)
12,1103,2166,920253419

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)onapristone (IC50)
Glucocorticoid receptorHomo sapiens (human)0.027
Prostaglandin G/H synthase 1Ovis aries (sheep)0.0027
Progesterone receptorHomo sapiens (human)0.0026
Mineralocorticoid receptor Homo sapiens (human)0.47
Androgen receptorHomo sapiens (human)0.269

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, BC; Eckel, RH; Gijón, MA; Hitz, CA; Jacobsen, BM; Schlaepfer, IR1

Other Studies

1 other study(ies) available for docetaxel anhydrous and onapristone

ArticleYear
Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel.
    Molecular and cellular endocrinology, 2012, Nov-05, Volume: 363, Issue:1-2

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Fatty Acids, Nonesterified; Female; Gene Expression; Glucose; Gonanes; Humans; Lipogenesis; Medroxyprogesterone Acetate; Phospholipids; Progestins; Receptors, Progesterone; Stearoyl-CoA Desaturase; Taxoids; Triglycerides

2012